Phone Number : 86-15209233790

WhatsApp : +8615209233790

123171-59-5 Cefepime Hydrochloride Powder C19H28Cl2N6O6S2

Contact Now

123171-59-5 Cefepime Hydrochloride Powder C19H28Cl2N6O6S2

Price :	$260.00 - $319.00/Kilograms	Packaging Details :	25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging aluminium bag<br>outside and double plastic bag inside.

Place of Origin:	Shaanxi, China	Brand Name:	Le-nutra
Model Number:	Le-nutra

Detail Information
CAS No.:	123171-59-5	Other Names:	Cefepime Dihydrochloride Monohydrate
MF:	C19H28Cl2N6O6S2	EINECS No.:	/
Type:	Animal Pharmaceuticals	Grade Standard:	Medicine Grade
Usage:	Animal Pharmaceuticals	Purity:	99%, 99%
English Name:	Cefepime Hydrochloride Powder	Appearance:	White Powder
Test Method:	HPLC	Grade:	Phamaceutical Grade
Molecular Formula:	C19H28Cl2N6O6S2	MOQ:	1KG
CAS:	123171-59-5	Odor:	Characteristic
Shelf Life:	2 Years	Port:	Tianjin/Shanghai/Qingdao
Highlight:	123171-59-5 Cefepime Hydrochloride , Cefepime Hydrochloride C19H28Cl2N6O6S2 , 123171-59-5 Hydrochloride Powder

Product Description

English name	Cefepime Hydrochloride powder
Purity	99%
Appearance	White powder
Odor	Characteristic
CAS	123171-59-5
Test Method	HPLC

Description

Cefepime hydrochloride

Cefepime hydrochloride is used to treat lower respiratory tract, urinary tract, skin and soft tissues, biliary tract, abdominal and pelvic cavity, gynecological and obstetric infections, and sepsis caused by sensitive bacteria. It is also used for empirical treatment of moderate and severe bacterial pneumonia.

Specification

Tests	Specifications	Result
Description	White powder	Meets the requirements
Identification	Meets the requirements	Meets the requirements
Water	3.0-4.%	3.2%
Crystallinity	Meets the requirements	Meets the requirements
Bacterial endotoxins	<0.04EU/mg	Meets the requirements
Residue on Ignition	≤0.1%	0.08%
Sterility	Meets the requirements	Meets the requirements
N-methylpyrrolidine	≤0.3%	Not detected
Heavy Metals	≤20ppm	<20ppm
Sterile	conform	complies
Related compounds
Cefepime related compound A	≤0.3%	Not detected
Cefepime related compound B	≤0.2%	Not detected
Any other impurity	≤0.1%	0.04
Assay	825~911ug/mg	856 ug/mg

Function and Application

Cefepime is indicated for the treatment of the following infections caused by susceptible bacteria:

1) Lower respiratory tract infections, such as pneumonia, bronchitis, etc. 2) Urinary system infections, such as pyelonephritis. 3) Skin and soft tissueinfections. 4) Intraperitoneal infections (including peritonitis and biliary infections, etc.). 5) Obstetrics and Gynecology infection. 6) Septicemia.

Pharmacological action

1. Cefepime hydrochloride is a fourth-generation cephalosporin whose antibacterial mechanism is to inhibit the synthesis and metabolism of bacterial cell wall by binding to one or more penicillin-binding proteins (PBPs) of bacterial cells, thereby exerting an antibacterial effect. Cefepime is characterized by high antibacterial activity, stable β-lactamase, especially chromosome-mediated Richmond-sykes type I β-lactamase, and very sensitive to Gram-negative bacilli producing type I β-lactamase Strong antibacterial activity. Cefepime has antibacterial activity against Enterobacter, Citrobacter and Serratia
producing type I β-lactamase over third-generation cephalosporins such as ceftazidime; antibacterial against Pseudomonas aeruginosa The effect is similar to or slightly worse than ceftazidime; the antibacterial activity against Gram-positive bacteria such as Staphylococcus aureus is also enhanced than that of the third-generation cephalosporin.

2. Gram-negative aerobic bacteria: Pseudomonas (including Pseudomonas aeruginosa, Pseudomonas putida), Escherichia coli, Klebsiella, Enterobacter (including Enterobacter cloacae, gas production) Enterobacter), variant bacillus (including Proteus mirabilis, common Proteus), citrate bacteria, Campylobacter jejuni, Haemophilus haemophilus, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, gonorrhea Neisseria, Neisseria meningitidis, Salmonella, Serratia, Shigella, Yersinia enterocolitica.

3. Anaerobic bacteria: Bacteroides, Clostridium perfringens, Clostridium, Streptococcus pneumoniae, and Weirong cocci. Cefepime hydrochloride has no antibacterial activity against most enterococci (such as Enterococcus faecalis, methicillin-resistant Staphylococcus), Pseudomonas maltophilia, Bacteroides fragilis, and Clostridium difficile.

Tag:

Dietary Supplement Powder(96)

Herbal Extract Powder(208)

Pure Vitamin Powder(49)

Empty Hard Capsules(81)

Men Health Supplements(17)

Antioxidants Powder(4)

Natural Food Colors(15)

API Powder(47)

Cosmetic Raw Materials(35)

Protein Nutrition Powder(11)

Nutritional Food Additive Powder(17)

Amino Acid Supplements(5)

Other Supplements(17)

Protein Peptide Powder(9)

Pure NMN Powder(10)

Fisetin Powder(5)

Coenzyme Q10 Powder(10)

123171-59-5 Cefepime Hydrochloride Powder C19H28Cl2N6O6S2

123171-59-5 Cefepime Hydrochloride

Cefepime Hydrochloride C19H28Cl2N6O6S2

123171-59-5 Hydrochloride Powder

Cefepime is indicated for the treatment of the following infections caused by susceptible bacteria:

Pharmacological action

Phenethyl Caffeate API Powder

CAPE Powder C17H16O4

Caffeic Acid Phenethyl Ester CAPE

Xi'an Le-Nutra Ingredients Inc